ArticleBMJ open2020

Protocol to assess the efficacy of carnosine supplementation in mitigating the adverse cardiovascular responses to particulate matter (PM) exposure: the Nucleophilic Defense Against PM Toxicity (NEAT) trial.

Timothy E O'Toole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.